Specifically, lincRNA-BC2 and lincRNA-BC5 showed increased expression in breast cancer tissues compared to matched normal tissues, whereas lincRNA-BC4 and lincRNA-BC8 were downregulated. This evidence concerns the gene CHMP2A and breast carcinoma.